Blue Water Biotech names Dr. Jay Newmark chief medical officer after Entadfi deal


Fresh off its multimillion-dollar acquisition of men’s sexual health drug Entadfi, Cincinnati-based Blue Water Biotech is adding a new role to its C-suite.

Previous Middlesex Savings names a woman to be CEO starting in 2024
Next Technology is shaping how WNY health care students learn